Apellis Pharmaceuticals Inc. (APLS) Slipped -5.55% or -1.41 To Price $23.99 On Tuesday


Apellis Pharmaceuticals Inc. (APLS) slipped -5.55% or -1.41 to $23.99. It is around 497501 shares traded, which is 180.65% compare to the average total volume 275394. The market cap of APLS is $1.34 billion. The year to date change is 22.23%. The 52 week price range is from $12.45 to $32.0. Price of APLS have changed 10.72% during last week. It have changed 11.31% over last month, 68.32% over last 3 months, 81.04% over last 6 months and 81.04% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for APLS is 23.51. It is -2.00% below current price. The 200-day Moving Averages for APLS is 19.28. It is -19.63% below current price. The 52-week High is 32.0. It is 33.39% from the current price. The 52-week Low is 12.45. It is -48.10% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of APLS is 11.87 on 2018-04-13. Short % to float is 3.33%. There are some statistics of APLS. It is has market cap $1.34 billion. The share outstanding is 55.94 million. The average volume is 275394. The percent of top 15 Institution holding is 48.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of APLS is -49.36%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of APLS is -39.03%.


Tags:

Share this post